The European Medicines Agency (EMA) has issued a marketing authorisation valid throughout the EU for a vaccine against a new type of haemorrhagic disease virus.

rabbit
Image: Tyler Olson / Fotolia.

Rabbit haemorrhagic disease virus type two (RHDV2) has affected rabbits in the UK and the Eravac vaccine, produced by Hipra Laboratories, is indicated for the active immunisation of fattening rabbits from the age of 30 days to reduce mortality caused by the disease.

Solution to a problem

If Eravac is not available or suitable, however, the VMD has said it will accept applications to import unauthorised medicines into the UK to treat RHDV2. Vaccines against RHDV2 authorised in other EU countries, meanwhile, which have previously been imported, include Filavac VHD K C+V from France and Novarvilap from Spain.

The VMD stated: “No information is available on the safety and efficacy of these vaccines for pet rabbit breeds, including when they are used at the same time as other vaccines (for example, classical RHDV or myxomatosis vaccines).

“Vets should use their clinical judgement in individual cases to decide the most suitable vaccination protocol. The vet should contact the vaccine manufacturer directly for further information.”

Further information on the authorisation is available on the EMA website.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Byre Vets in Werrington, Peterborough, Cambridgeshire is the latest to be added to a network of practices located in the nearby towns of Oundle, Thrapston, Corby and Stamford.

4 mins

Vets and VNs can play their part in improving rabbit welfare in clinics by taking part in an online study from the University of Bristol.

3 mins

Talking about money with clients is not always a part of the job veterinary professionals enjoy. Here, Stewart Halperin gives his top tips for helping your team take the pain out of asking for payment.

23 mins

Former NOAH chairman Philip Lowndes has been announced as the new chairman of the BVA board.

3 mins

Vicky Robinson discusses why it's important to see beyond the obvious ‘cute factor’ and recognise the significant clinical and commercial factors implicit in the arrival of a new puppy or kitten.

19 mins

Nova Laboratories is gearing up to showcase its range of personalised pet medicine at the Veterinary Education for Tomorrow Festival 2017.

2 mins